Treatment of sialorrhea in children with Cerebral Palsy: A double-blind placebo controlled trial

Clinical Neurology and Neurosurgery

Volumn 111, Issue 1, 2009, Pages 79-82

  Alrefai, Ali H ^a   Aburahma, Samah K ^a   Khader, Yousef S ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Botulinum toxin; Cerebral palsy; Drooling

Indexed keywords

BOTULINUM TOXIN A;

ABSENCE OF SIDE EFFECTS; ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERSALIVATION; MALE; RATING SCALE; TREATMENT OUTCOME;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; MALE; PAROTID GLAND; PROSPECTIVE STUDIES; SALIVA; SIALORRHEA; TREATMENT OUTCOME;

EID: 57549112386     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.09.001     Document Type: Article

References (22)

1. Lipp A., Trottenberg T., Schink T., Kupsch A., and Arnold G. A randomized trial of Botulinum toxin A for treatment of drooling. Neurology 61 (2003) 1279-1281
2. Harris S.R., and Purdy A.H. Drooling and its management in cerebral palsy. Dev Med Child Neurol 29 (1987) 807-811
3. Van de Heyning P.H., Marquet J.F., and Creten W.L. Drooling in children with cerebral palsy. Acta-Oto-Rhino-Laryngol Belgica 34 (1980) 691-705
4. Bachrach S.J., Walter R.S., and Trzcinski K. Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy. Clin Pediatr 37 (1998) 485-490
5. Domaracki L.S., and Sisson L.A. Decreased drooling with oral motor stimulation in children with multiple disabilities. Am J Occup Ther 44 (1990) 680-684
6. Rosen A., Komisar A., Ophir D., and Marshak G. Experience with the Wilkie procedure for sialorrhea. Ann Otol Rhinol Laryngol 99 9 Pt 1 (1990) 730-732
7. Crysdale W.S., and White A. Submandibular duct relocation for drooling: a 10-year experience in 194 patients. Otolaryngol Head Neck Surg 101 (1989) 87-92
8. Bothwell J.E., Clarke K., Dooley J.M., Gordon K.E., Anderson R., Wood E.P., et al. Botulinum toxin a as a treatment for excessive drooling in children. Pediatr Neurol 27 (2002) 18-22
9. Jongerius P.H., Rotteveel J.J., Limbeek J.V., Gabreëls F.J., Van Hulst K, and Van den Hoogen F.J. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology 63 (2004) 1371-1375
10. Suskind D.L., and Tilton A. Clinical Study of Botulinum-A Toxin in the Treatment of Sialorrhea in Children with Cerebral Palsy. Laryngoscope 112 (2002) 73-81
11. Jongerius P.H., Rotteveel J.J., Van den Hoogen F., Joosten F., Van Hulst K., and Gabreëls F.J. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy Presentation of case series. Eur J Pediatr (2001) 160:509:512
12. Stonell T.N., and Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 3 (1988) 73-78
13. Glickman S., and Deaney C.N. Treatment of relative sialorrhea with Botulinum toxin type A: description and rationale for an injection procedure with case report. Eur J Neur 8 (2001) 567-571
14. Becks H., and Wainwright W. Human saliva: rate of flow of resting saliva of healthy individuals. Neurogastroenterol Motil 22 (1943) 391-396
15. Enfors B. The parotid and submandibular secretion in man. Acta Otolaryngol 172 (1962) 1-67 (suppl)
16. Lin Y., Shieh J., Cheng M., and Yang P. Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy. Neurology 70 (2008) 316-318
17. Reid S.M., Johnstone B.R., Westbury C., Rawicki B., and Reddihough D.S. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders. Dev Med Child Neurol 50 (2008) 123-128
18. Savarese R., Diamond M., Elovic E., and Millis S.R. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Am J Phys Med Rehabil 83 4 (2004) 304-311
19. Jongerius P.H., van den Hoogen F.J., van Limbeek J., Gabreëls F.J., van Hulst K., and Rotteveel J.J. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics 114 3 (2004) 620-627
20. Banerjee K.J., Glasson C., and O'Flaherty S.J. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Dev Med Child Neurol 48 11 (2006) 883-887
21. Dogu O., Apaydin D., Sevim S., Talas D.U., and Aral M. Ultrasound-guided versus 'blind' intraparotid injections of Botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. Clin Neuro Neurosurg 106 (2004) 93-96
22. Pal P.K., Calne D.B., Calne S., and Tsui J.K.C. Botulinum toxin A as treatment for drooling saliva in PD. Neurology 54 (2000) 244-247